Aster Capital Management »

Zenas Biopharma shares owned by Aster Capital Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.5k 339 22.20

More positions owned by Aster Capital Management

Johnson & Johnson (JNJ)
Capital One Financial (COF)
Wal-Mart Stores (WMT)
Abbott Laboratories (ABT)
Hca Holdings (HCA)
Wells Fargo & Company (WFC)
Home Depot (HD)
Bank of America Corporation (BAC)
Pulte (PHM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Citigroup Com New (C)
Raymond James Financial (RJF)
Abbvie (ABBV)
Ishares Tr Ishares Biotech (IBB)
Carlisle Companies (CSL)

View all positions for Aster Capital Management

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Novo A/S
Fairmount Funds Management
Federated Investors
NVP Associates
Deerfield Management Company
BlackRock
Vivo Capital
Vanguard Group
Wellington Management Company
Arrowpoint Asset Management
Pivotal bioVenture Partners Investment Advisor

View all funds holding Zenas Biopharma